Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Jason Cheng

1PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Sep 13, 2023
Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung Cancer.

Bruna Pellini, Russell W Madison, Merrida A Childress

Pageof 1

Frequent Collaborators

1 joint publications

Bruna Pellini

1 joint publications

Russell W Madison

1 joint publications

Merrida A Childress

1 joint publications

Shoshana T Miller

1 joint publications

Ole Gjoerup

1 joint publications

Richard S P Huang

1 joint publications

Michael Krainock

1 joint publications

Pratyush Gupta

1 joint publications

Wei Zou

1 joint publications

David S Shames

Frequent Collaborators

1 joint publications

Bruna Pellini

1 joint publications

Russell W Madison

1 joint publications

Merrida A Childress

1 joint publications

Shoshana T Miller

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

5.0K
See more related videos

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

5.0K
See more related videos